In concordance, the existence of higher frequencies of PD-1 expressing CD8+ T cells in TDLNs compared with non-TDLNs has been reported in several solid mouse tumor models, irrespective of cancer type, mouse genetic background or tumor localization.33 The gene discussed is CD8A; the disease is cancer.